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The era of next-generation sequencing has mounted the foundation of many gene expres-
sion studies. In rheumatoid arthritis research, this has led to the discovery of important can-
didate genes which offered novel insights into mechanisms and their possible roles in the
cure of the disease. In the last years, data generation has outstripped data analysis and
while many studies focused on specific aspects of the disease, a global picture of the dis-
ease is not yet accomplished. Here, we analyzed and compared a collection of gene expres-
sion information from healthy individuals and from patients suffering under different arthritis
conditions from published studies containing the following clinical conditions: early and
established rheumatoid arthritis, osteoarthritis and arthralgia. We show comprehensive
overviews of this data collection and give new insights specifically on gene expression in the
early stage, into sex-dependent gene expression, and we describe general differences in
expression of different biotypes of genes. Many genes that are related to cytoskeleton
changes (actin filament related genes) are differently expressed in early rheumatoid arthritis
in comparison to healthy subjects; interestingly, eight of these genes reverse their expres-
sion ratio significantly between men and women compared early rheumatoid arthritis and
healthy subjects. There are some slighter changes between men and woman between the
conditions early and established rheumatoid arthritis. Another aspect are miRNAs and other
gene biotypes which are not only promising candidates for diagnoses but also change their
expression grossly in average at rheumatoid arthritis and arthralgia compared to the healthy
condition. With a selection of intersecting genes, we were able to generate simple classifica-
tion models to distinguish between healthy and rheumatoid arthritis as well as between early
rheumatoid arthritis to other arthritides based on gene expression.
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Introduction
Rheumatoid arthritis (RA) is a chronic, complex, systemic, multifactorial disease [1, 2] with a
prevalence of 0.3–1% in the population worldwide [3], affecting women 2–3 times more often
than men. The proven or at least strongly suspected etiopathogenetic factors include genomic
variations [4], gene expression changes [5], autoimmunity [6] and environmental factors [7].
No factor is considered as single cause, except for the (currently unknown) cause of the first
insult leading to the autoimmune inflammation characteristic of RA. Likely, there is not one
single cause of RA, no single path to progression and no single curative approach, as ultimate
success rates of single therapies are limited [8, 9]. This has led to the hypothesis that there
might be RA subtypes with different RA disease manifestations that are dependent on sex,
genotype, gene expression or on the composition of the microbiome, which would make RA
an important showcase for personalized medicine.
A lot of effort has been undertaken in finding or assessing specific genes and pathways of
importance for the progression of RA [10–13]. Less effort has been spent so far to obtain a
more complete view of the complete genome and expression data. The analysis of whole
genome sequencing data of RA is covered in broader GWAS approaches (e.g. [4, 14], where
several associated SNPs were reported), while gene expression data from RNA-seq is more left
open for the broader view and was generated for particular research questions [15, 16]. Some
broader views of gene expression are published based on microarray data [17–19], as well as
some narrower views based on quantitative polymerase chain reactions (PCRs) of several
genes [20–22]. The prevalence of RA is lower in men than in women [23–26], but it is unclear
whether this is also related to gene expression; reported relations with sex hormones such as
estrogen and androgen would be supportive of this hypotheses [27]. If such major differences
of gene expression between men and women exist specifically in RA compared to healthy sub-
jects, these genes might be targets for further investigation as there might be sex-specific issues
beside the prevalence.
Some miRNAs have been also reported as related to RA, with the main motivation to use
them as diagnostic markers for RA [28, 29]. Despite the different alternatives for the initial
starting points of RA and potential diagnostic markers, there is a consensus regarding the cen-
ter of amplification and perpetuation of joint inflammation: the synovial tissue [30, 31].
Uncontrolled persistent inflammation of the synovial membrane leads to progressive joint
damage and disability [2]. For this reason, we focus the present analyses on gene expression
(RNA-seq) data from synovial tissue. We use published studies with large amounts of RNA-




Clustering of subjects and conditions. We applied different clustering and dimension
reduction methods to obtain a comprehensive view of the transcriptome data from the 236
RNA-seq synovial biopsy samples. A PCA is shown in Fig 1, divided in panels, where only
some conditions are shown (because of large overlaps; all conditions together are shown in S1
Fig). On a high-level view, gene expression of healthy subjects is quite different compared to
the non-healthy conditions (Fig 1D; classification model accuracy of 95%, p-value of separa-
tion between healthy and non-healthy (excluding OA) is 4.4�10−18 when the coordinates of the
first two components of the PCA and the labels for the samples were taken and treated as a
classification problem for the tree learner learner C4.5 [32]). Established RA is quite broad and
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Fig 1. The first two principal components of the PCA based on the RPKMs of the coding genes. The areas are the convex hulls of the
conditions. The largest point of one color depicts the center of a hull. A, B, and D are the same PCA analysis with the same coordinates,
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overlaps with all other groups. Arthralgia is clearly different from early RA as the convex hull
is not overlapping at all (Fig 1). Different clustering approaches do not entail more insights
than PCA (Conformal Eigenmaps [33], multidimensional scaling [34] and Sammon mapping
[35], see S2–S4 Figs). Fig 2 shows the same overview for the conditions when split by sex and
by only using the three conditions where more than ten samples for men and women exist
(conditions early RA, established RA and healthy; for an overview of the first 10 principal com-
ponents see S5 Fig). There is not much visible difference between men and women, as all con-
ditions are highly overlapping in the first two principal components whether samples originate
from male or female individuals.
Looking into clustering within one diagnosis reveals potential subtypes (PCA and hierar-
chical clustering in Supplementary Archive FiguresClusteringWithinClasses/). For example,
there is a kind of female cluster within early RA (Supplementary Fig ’earlyRA_hclust’). When
filtering for genes, which are significantly differently expressed in at least one comparison to
normal, the similarity of conditions based on the fold-change can be assessed (S6 Fig). OA is
there located next to samples from healthy individuals, a strong treatment (RAtripleDMARD)
constitute the next neighbor and early/established RA conditions group apart. When restrict-
ing to miRNAs, the picture is similar: only the closer conditions are a little bit rearranged (S7
Fig). Hierarchical clustering instead of neighbor joining and PCA are shown in S8 Fig for cod-
ing genes and in S9 Fig for miRNAs.
Gene enrichment analysis
In order to better understand the differences in gene functions between the different condi-
tions, we performed a gene enrichment analysis. We looked for GO [36, 37], KEGG [38] and
REACTOME [39] enriched terms in the significantly differentially expressed genes between
the clinical conditions and various derived gene lists. This includes all gene lists used and gen-
erated in this article (see in the Supplementary Archive tables/ and geneSets/ for all enrich-
ments and gene lists). An overview of GO (BP) term enrichments of the comparisons of
normal to earlyRA, arthralgia, OA and undifferentiated arthritis is shown in Fig 3. More details
about tools and strict filtering settings needed for a diagram fitting onto a single page are in
the method section. The GO terms in a larger font therein were selected for their specifity for
earlyRA and meaningfulness. For example, in the upper right cluster, the term ’vesicle-medi-
ated transport’ might be interesting, but is enriched in the up-regulated genes of all four condi-
tions. The term ’cell activation’ is specifically enriched in up-regulated genes in earlyRA, but
the term itself is rather nonspecific. Taken the GO terms of DEGs in earlyRA together, there is
specifically more expression for chromatin (lower right in Fig 3), coagulation factors (as also
reported in several articles [40–42]), less activity of polymerase II (as can also be seen in section
’Different gene expression at different gene biotypes’), less muscle cell activity (see section ’Dif-
ferent RA gene expression in men and women’ for a more detailed different view on that) and
more antigen presentation (left side in Fig 3). Other patterns in this view are also interesting,
like enrichment specifically for earlyRA and undifferentiated arthritis as these conditions are
clinically quite close. For example, the Gene Ontology terms ’biological adhesion’, ’regulation
of cell-cell adhesion’ and ’immunoglobulin production’ are enriched in earlyRA and UA, but
not in OA and arthralgia (left in Fig 3). Unfortunately, there are only few samples for undiffer-
entiated arthritis, which weakens the hints from these patterns. The complete enrichment lists
where in D all conditions except OA are visible, in A and B only three of them for a better overview. C is a PCA with OA, where four
conditions are shown to depict the variability of OA. Number of samples: 10 arthralgia, 57 earlyRA, 95 establishedRA, 27 normal, 22 OA,
19 RAtripleDMARD and 6 UA.
https://doi.org/10.1371/journal.pone.0219698.g001
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in the Supplement give a more detailed view, in the main text and in the next sections we focus
on single effects on the top-level.
Different RA gene expression in men and women
Within each clinical condition there are 85 to 101 genes differentially expressed when compar-
ing men and women within the 236 RNA-seq synovial biopsy samples. Some of these genes
are also differentially expressed in early RA compared to normal condition and some of these
genes reverse their expression sex-ratio between normal and early RA. This is shown in Fig
Fig 2. The first two principal components of the PCA considering RPKMs of the coding genes. The areas are the convex hull of the condition. The largest point of one
color depicts the centers of the hull. Only those conditions are shown where more than ten samples were available for male and female individuals. Number of samples: 33
earlyRAF, 24 earlyRAM, 73 establishedRAF, 22 establishedRAM, 13 NormalF, 14 NormalM.
https://doi.org/10.1371/journal.pone.0219698.g002
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4A, where all genes exhibiting a threefold change can be found in the lower right quadrant.
This means that there exist not only genes which are significantly differentially expressed
when comparing the normal condition with early RA, but of which some are also significantly
lower in healthy males and significantly higher in males with early RA. These genes are
ATP2A1, LMOD2, ACTN2, DES, CKM, NRAP, MYH2, XIRP2 and RP11−766F14.2 where all
but the last are related to muscles according to the GeneCards database [43] (muscle filament,
sarcomere and actin filament). A Gene Ontology term enrichment shows the same, all terms
assigned to more than one of the nine genes are related to muscles and actin organization (see
Supplementary Archive tables/ for enrichment, where this set is named ’earlyRAdown_Nor-
malFM_down_earlyRAFMup_ageFilter’). As no muscle cells should be present in synovial
biopsies, the substantial GO-term in this context refers to cytoskeleton changes (change of
expression of actin filament related genes). For RP11-766F14.2 only little is known—maybe
because of its just recent aliases [44], where its role in obliterative portal venopathy is
described.
The same comparison between early and established RA (Fig 4B) has no threefold signifi-
cantly differentially expressed genes, but shows two things: the aforementioned genes for cyto-
skeleton changes are different between earlyRA and establishedRA, this special difference in
men and women is only present at earlyRA (see also S10 Fig for the same comparison between
establishedRA and normal condition), and secondly, that some cytokines and the two genes
Fig 3. GO (BP) term enrichments of DEGs in earlyRA, arthralgia, OA and undifferentiated arthritis. Base state is normal, each term has the DEG enrichment
of the four conditions in the circle’s quadrants according to the legend bottom right. Red indicates there is an enrichment in the upregulated DEGs, blue indicates
an enrichment in the down-regulated DEGs and gray indicates no enrichment. The node size represents the number of genes in the annotation for that term. The
edge thickness represents the degree of overlap between the gene-sets of two terms. The terms in a larger font are a selection for meaningful terms specifically for
earlyRA (somewhat arbitrary). See methods and main text for filtering and discussion. Number of samples: 10 arthralgia, 57 earlyRA, 22 OA and 6 UA.
https://doi.org/10.1371/journal.pone.0219698.g003
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PTGS2 and TFPI2 are stronger expressed in men with established RA. Beside the cytokines,
also the latter two genes have been also investigated for RA (PTGS2 is more often referred to
as COX-2) [45–47].
The comparison between OA and normal condition is unremarkable (S11 Fig).
Different gene expression at different gene biotypes
We then assessed the average expression change of different gene biotypes (as defined as bio-
types by Ensembl [48]) in the 236 RNA-seq synovial biopsy samples (Fig 5 and S2 Table). The
base state is defined there as the normal condition. The positive and negative average fold-
changes in Fig 5B are roughly corresponding to the count of significantly differently expressed
genes (corresponds to the difference in counts; Fig 5A). rRNAs of mitochondria are less
expressed in RA conditions and arthralgia, while the normal rRNA is much higher expressed
in arthralgia and miRNAs are less expressed in RA conditions and arthralgia. Generally, there
is a pattern of lower gene expression in RA and arthralgia. It seems unexpected that in this
sense undifferentiated arthritis is not similar to the RA conditions, as undifferentiated arthritis
has clinical signs of synovitis, but ’just’ failing to meet the 2010 American College of Rheuma-
tology criteria [49] for RA. When taking a closer look, it does not look contradictory; in both
conditions many genes related to the immune system are highly up-regulated, but in RA even
more genes are down-regulated (more than up-regulated and many more than down-regu-
lated in undifferentiated arthritis). The down-regulated genes in early RA seem to have very
Fig 4. Log2 fold-changes of gene expression between men and women in early RA, established RA and normal condition. Only genes are shown which are
significantly differentially expressed in men and women. (A) The sex-ratio of gene expression in early RA and normal condition. The size and shape shows the significance
in differences of men and women: the large circles are genes significantly differentially expressed between the sexes in early RA and normal condition, these genes are also
labelled. Small squares mean a significant difference between men and woman only in early RA, small diamonds mean a significant difference only between healthy men
and woman. The color represents the significance of the difference in expression between normal and early RA. (B) The sex-ratio of gene expression in established RA and
early RA. There are no gene significantly differentially expressed in men and women in established RA and early RA and differentially expressed between established RA
and early RA. Genes are named if one of the gene expression sex-ratios is significant: squares mean a significant difference between men and woman only in established
RA, small diamonds mean a significant difference only between men and woman in early RA.
https://doi.org/10.1371/journal.pone.0219698.g004
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Fig 5. Average fold-changes and counts of different biotypes of genes. The labels on the x-axis mean the change of this condition relative to normal. Only significant
changes are regarded. The labels for the biotypes of genes are defined by Ensembl (the biotypes of genes). Missing bars mean that there was no significant change in any
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different functions compared with the up-regulated genes, except genes related to immune sys-
tem activation; the most prominently enriched GO-terms are related to cytoskeleton changes
(see Supplementary Archive tables/ for the various term enrichments of these genes).
Classification models
Based on the RNA-seq samples and certain gene sets, we were able to generate classification
models with significance in an internal cross-fold validation to distinguish early RA from the
normal condition and early RA from other diagnoses (Fig 6 and Fig 7). For the comparison of
early RA with normal condition, we selected the intersection of genes differentially expressed in
the single-variable comparisons normal vs early RA, normal vs OA, normal vs. undifferentiated
arthritis and normal vs. arthralgia. This resulted in 45 differentially expressed genes. RPKMs of
these genes are the input for generating models. One of the best and also quite the simplest
model is a PART [50] model with only one rule, which is visualized in Fig 6. For the comparison
of early RA to other arthritides (undifferentiated arthritis, OA, arthralgia) we selected the inter-
section of genes differentially expressed in the single-variable comparisons of early RA vs nor-
mal, early RA vs arthralgia and early RA vs OA (it would be no gene left when including early
gene of this biotype. (A) The log10 count of the significantly differentially expressed gene by biotype. Each column consists of two bars: from 0 to the positive side are the
(log10) numbers of significantly higher expressed genes, from 0 to the negative side are the numbers of significantly lower expressed genes. (B) The average log2 fold-
change of the significantly differentially expressed genes. It is to see that the average log2 fold-change roughly corresponds in the difference of the counts of the
significantly higher and lower expressed genes. Number of samples: 10 arthralgia, 57 earlyRA, 95 establishedRA, 27 normal, 22 OA, 19 RAtripleDMARD and 6 UA.
https://doi.org/10.1371/journal.pone.0219698.g005
Fig 6. Classification model for distinguish between early RA and normal based on RPKMs. The model consists only of the single rule LXN> 3.8 AND
CXCL8> 0.04 -> early RA. It corresponds to an accuracy of 92% at the 10-fold cross-validation (p-value 2.02�10−13). Variables for model-generation
were pre-selected upon the intersection of single-variable comparisons. This pre-selection weakens the cross-validation as it is no part of it. This model is
only intended for a distinction between early RA and normal as simple as possible based on gene expression. In total there are 84 samples. The RPKM
values are cut at 10 and at 1, respectively.
https://doi.org/10.1371/journal.pone.0219698.g006
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RA vs undifferentiated arthritis in the intersection). This resulted in 94 differentially expressed
genes. Also for this classification, a PART model is one of the best. It consists of four rules,
which are shown in Fig 7. An overview of other model performances is shown in S3 Table. For
Fig 7. Classification model for distinguish between early RA and not healthy but also not RA based on RPKMs. ’not RA’ as present in the data, which is
OA, arthralgia and undifferentiated arthritis, shortcut ’notRAarth’. The model consists of four rules, where three of them are shown here graphically. Panels
A and B depict the first rule, where in B are only cases left which are higher than the threshold in A. The red shaded area in B shows the cases hit by the first
rule, which are all earlyRA. Panel C shows the second and third rule, where the model output for the red shaded area is earlyRA and for the blue shaded area
is notRAarth. The complete model as text is shown in D. The threshold values are rounded to one decimal place. The model corresponds to an accuracy of
86% at the 10-fold cross-validation (p-value 1.7�10−12). Variables for model-generation were pre-selected upon the intersection of single-variable
comparisons. This pre-selection weakens the cross-validation as it is no part of it. This model is only intended for a distinction between early RA and other
conditions as simple as possible based on gene expression. In total there were 95 samples as input data.
https://doi.org/10.1371/journal.pone.0219698.g007
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an overview of single variable importance measured with information gain [51] and reliefF [52]
see S4 Table. The selection of genes based on single-variable comparisons as input for genera-
tion classification models weakens the validity of the internal cross-fold validation, but is never-
theless more solid than the direct group wise comparison (e.g. just normal vs early RA) without
any validation. The genes which were selected for the models are not unknown: LXN is known
to be upregulated in early OA [53] and not only as part of the inflammatory response but also
influencing the perception of pain [54]; several CXCL genes (chemokines) have been shown to
be upregulated at RA, also CXCL8 [11, 12]; MAB21L2 is upregulated especially in OA [55];
about the RP11-� genes less is known as these labels are still their original clone ID [56].
Discussion
In this analysis, we have added several new views, hints and insights about gene expression in
RA. Some of these approaches had been tried on former, limited microarray data in the one or
other similar way [18, 19, 57–60]. Compared with these results, it makes sense to to repeat the
same or similar types of analyses with recent RNA-seq data. With this recent data, we got sev-
eral new conclusions. First, the clustering and dimension reduction gives a highly informative
and high-level view of RA and related diagnoses; it shows the major difference of the healthy
and the unhealthy conditions. Such high-level views are presented in several papers (as in the
microarray papers mentioned before); here it is shown with more sensitive RNA-seq data.
Clustering
The clustering and dimension reduction shows in brief certain high-level differences between
the conditions (Fig 1), no differences between men and woman on the highest level (Fig 2), no
differences between men and woman at gene cluster level (S12 Fig) and expected vicinity of
the conditions by their fold-changes (S6 Fig). OA and establishedRA covers the largest area in
the PCA, which might be related to their loose definition, both are samples any time after their
first diagnosis (establishedRA at least 12 months after treatment start).
Overlaps in gene lists
S13 and S14 Figs give a summary of all overlaps between three and four conditions. The
amount of linking arcs might be overwhelming at the beginning, but every link can be located
with one close look. Venn diagrams are the straightforward choice to visualize overlaps, but
they are unsightly with more than 4 or 5 sets, except maybe the famous six-way banana Venn
diagram [61]. In the S13 and S14 Figs we have 9 and 12 sets.
Men and women
We showed with gene expression data that significant differences between men and women
exist at least on a detailed view on RA (Fig 4; Fig 2 for the high-level view). The set of genes
being three-fold significant (significantly differentially expressed in normal vs. early RA, in
men vs women in normal and early RA, but with reversed sign, see Fig 4A) looks a bit out of
place for synovial tissue with their term enrichment for muscles (muscle filament and sarco-
mere), but these are also enriched for actin filament reorganization. It is known that rearrange-
ments in the cytoskeleton are associated with RA [62, 63]. This seems in this dataset specific
for earlyRA. At establishedRA several genes related to the immune system are higher
expressed. Some of these genes were already reported as sex-biased genes [64], here we show a
particular instance. These ’RA-cytoskeleton-genes’ and these sex-biased immune system genes
are solid points for further investigation, as they might be targets for therapy, responsible for
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some side effects different in men and women, the effect of different behavior after progression
of RA or just be an artifact unknown to now.
Gene biotypes
In the high-level view of gene biotypes, we see a clear pattern of generally lower gene expres-
sion and more genes significantly down-regulated in RA and arthralgia (Fig 5). This give rise
to the hypothesis that the miRNA diagnostic marker(s) for RA—what many are looking for
[29, 65, 66]—might be negative ones (that means the lack of certain miRNAs would point to
RA), although it might be confused with arthralgia. The rRNA is worth extra attention as it is
the major difference between arthralgia and the rest. rRNAs of mitochondria are less expressed
in RA conditions and arthralgia, likely because of the hypoxic microenvironment [67, 68], but
also possible associated with general exhaustion [69, 70].
Classification models
For the simplest distinction between RA and other conditions, we provide two classification
models. The genes used in the models might not be causative or functionally most related, but
are a minimal set of genes to classify the data, which classification in that way is also significant
at 10-fold cross-validation. The pre-selection of genes based on intersecting single-variable
comparisons is needed for escaping the curse of dimensionality for multivariable classification
methods. This pre-selection has some limitations: it has itself no internal validation and the
gene sets from the single-variable comparisons are differently solid, as there are conditions
with different sample sizes (smallest: 6 samples of UA and 10 of arthralgia). This increases the
chance to lose the ’best’ (= most likely causative) predictors and getting instead the most corre-
lated (to the ’best’ predictors) variables in the model. This pre-selection weakens the validity of
the internal cross-fold validation. The used classification method (PART [50], a tree learner
based rule generator) is likely over-simplifying RA. For final assessments of the particular—
potential causal—functions of the selected predictors, dedicated wet lab experiments are
needed. The presented classification models are only intended for a distinction between RA
and other conditions as simple as possible based on gene expression.
Previous microarray studies
Many RNA-seq data is already published for RA, as used in this article; more sample data is
still available from microarrays. Single cell sequencing RNA-seq samples are catching up in
number and of course depth, but previous microarray data are still a large source to compare
with. The comparison of the collected RNAseq data with suitable previous microarray studies
shows expected results (S1 Text, especially S15 Fig). The fact that the relative overlap of the up-
regulated genes is always higher than of the down-regulated genes could point to a bias of seen
importance (= more solid annotation, as this have changed over time) of these up-regulated
genes or to a higher biological importance of these genes (as they are more overlapping in
independent studies). Overall, it seems important to use RNA-seq data instead of microarray
data for the transcriptome, to use the very same gene annotation and to process the data in the
very same way. In such collections are likely still plenty of hidden insights.
Material and methods
Data collection
We have combined and compared 236 RNA-seq synovial biopsy samples from the papers of
Walsh et al. and Guo et al. [15, 16] and microarray data from the papers of Liu et al., Teixeira
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et al., Niu et al. and Yoshida et al. [18, 58–60] in this study. This RNA-seq sample collection
was chosen, because it is consistent, large and there are open questions for which insights or at
least hints are in this data. The main data are the 236 RNA-seq samples, the microarray data
are only used for showing the overlaps with the main data.
The samples of Teixeira et al. and Niu et al. are from peripheral blood (Peripheral Blood
Mononuclear Cells—PBMCs), whereas all other samples are from synovial tissue. RNA-seq data
were downloaded from the Sequence Read Archive (SRA) [71] (see S1 Table for accession identi-
fiers and number of samples per diagnosis), microarray and clinical data were taken as presented
in the original papers. The raw RNA-seq data were processed as described in the next section,
the clinical information was taken as provided in the source papers [15, 16], where ‘normal’
refers to healthy patients, ‘arthralgia’ refers to a population based on this symptom, rather than a
specific diagnosis, ‘earlyRA’ means treatment naïve RA within 12 months of first diagnosis,
‘establishedRA’ means treatment experienced RA of>12 months disease duration, ‘RAtripleD-
MARD’ means RA about 6 months after treatment initiation with methotrexate, sulfasalazine
and hydroxychloroquine, finally ‘OA’ means osteoarthritis and ‘UA’ means undifferentiated
arthritis. ’establishedRA’ and ‘RAtripleDMARD’ are both patients under ongoing treatment,
where the latter was a specific treatment and the sample after a certain time (6 months after treat-
ment start) and the former are patients at/after any treatment after a longer period of time (>12
months after treatment start) [16]. Undifferentiated arthritis is defined as clinical signs of synovi-
tis, but failing to meet the 2010 American College of Rheumatology criteria for RA [16]. An ‘F’
or an ‘M’ appended to a label means the subset of female and male patients.
RNA-seq—primary data processing
Reads were mapped onto the human reference genome release hg38 (GRCh38) [72] with
Ensembl transcript annotation version 87 [48] using Tophat version 2.1.1 [73] with Bowtie
version 2.2.9 [74]. Reads were counted with featureCounts [75] and gene expression values
(reads per kilobase exon per million mapped reads (RPKM)) were calculated with Cufflinks
version 2.2 [76]. The differential expression between two sample groups was calculated with
edgeR [77]. The filtering for differentially expressed genes is for p-value of 0.05 (FWER cor-
rected) and minimal fold-change of 2. In the more specific analyses for single genes, for the dif-
ferences in men and woman and for classification models, (healthy) age-related genes are
removed. This is because the sampled healthy subjects are in average quite younger than the
subjects with different arthritis conditions and at comparisons between them age-related
genes are expected to be significantly different. Age-related genes are taken from Yang et. al.
[78]. We performed also comparisons of gene expression between groups adjusted for age. At
the most changing adjustment in the comparison between healthy subjects and early RA (an
average age of 35.2 vs. 55.9), we realized that many genes well known for RA are filtered (as
CCL19 [79], CCL22 [80], CCR6 [81], CD6 [82], CDH11 [83], IFIT1B (as a paralog to IFIT1
[84]), IL26 [85], IL2RB [86], MMP10 [87], MMP12 [88], MMP8 [89] and MMP9 [90]). Similar
worrying are the overlaps between unique DEGs in the comparison unadjusted and adjusted
by age with the external age-related genes (as used for filtering from Yang et al. [78]), we see
even a higher overlap between age-adjusted DEGs (healthy vs early RA) and the external age-
related genes. Given that, we used the comparison without adjustment for further analyses.
Age-adjusted comparisons are available in the Supplementary Archive.
Clustering and dimension reduction
The RPKM values per gene were the input for clustering. The standard R [91] functions were
used for PCA and hierarchical clustering, as well as the interfaces of the visualization libraries
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(described in section visualization). For other dimension reduction methods the Matlab
Toolbox for Dimensionality Reduction was used [92].
Co-expression analysis
For clustering genes into modules based on their expression profiles over all conditions, we
used the expression of the transcript with the highest expression per gene. We grouped sam-
ples into conditions by choosing the median expression per gene and used this information as
input for the Weighted Gene Co-expression Network Analysis (WGCNA) method [93]. Genes
were kept only if the total cumulative RPKM over all samples was more than 10 and when
exceeding the standard deviation of 0.5 along all conditions.
Gene enrichment analyses
For Gene Ontology (GO) [37] enrichment analysis of a gene set, GOstats version 2.46.0 [94]
was used with default parameters, except the parameter ’conditional’, which was set to TRUE
(which removes genes from significant terms deeper in the hierarchy). For the detection of
enriched KEGG [38] and REACTOME [39] terms geneSCF version 1.1 [95] was used. All
complete lists are available in the Supplementary Archive (tables/). For having a diagram of
the GO (BP) terms fitting onto a single page (in Fig 3), we used REVIGO [96] for reducing
overlapping terms with an allowed similarity threshold of 0.4 and the Cytoscape [97] plugin
EnrichmentMap [98] for visualization with a threshold of 10−6 for the raw p-values and an
edge similarity threshold of 0.5.
Visualization
For the visualization of clusters, distributions, overlaps, correlations and ratios we used the fol-
lowing R packages: ape [99], vioplot [100], dplyr [101], ggplot2 [102], ggrepel [103], FactoMi-
neR [104], factoextra [105] and WGCNA [93]. Additionally, we used the tools Cytoscape [97]
and Circos [106].
Machine learning for classification models
For the following classification methods, the reference implementation in WEKA [107] was
used: C4.5 [32] (implemented as J48), PART [50], Alternating Decision Trees [108], naive
Bayes [109], SMO [110]. The importance of variables was measured with their information
gain [51] and reliefF [52] as implemented in WEKA.
Supporting information
S1 Fig. The first two principal components of the PCA based on the RPKMs of the coding
genes. The areas are the convex hulls of the conditions. The largest point of one color depicts
the center of a hull. Number of samples: 22 OA, 10 arthralgia, 57 earlyRA, 95 longRA, 27 nor-
mal, 19 RApost and 6 UnArth.
(TIF)
S2 Fig. Conformal Eigenmaps (CCA) based on the RPKMs of the coding genes. Number of
samples: 22 OA, 10 arthralgia, 57 earlyRA, 95 longRA, 27 normal, 19 RApost and 6 UnArth.
(TIF)
S3 Fig. Sammon mapping based on the RPKMs of the coding genes. Number of samples: 22
OA, 10 arthralgia, 57 earlyRA, 95 longRA, 27 normal, 19 RApost and 6 UnArth.
(TIF)
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S4 Fig. Multidimensional scaling (MDS) based on the RPKMs of the coding genes. Number
of samples: 22 OA, 10 arthralgia, 57 earlyRA, 95 longRA, 27 normal, 19 RApost and 6 UnArth.
(TIF)
S5 Fig. The first ten principal components of the PCA considering RPKMs of the coding
genes. The areas are the convex hull of the condition. The largest point of one color depicts the
centers of the hull. Only those conditions are shown where more than ten samples were avail-
able for male and female individuals. Number of samples: 33 earlyRAF, 24 earlyRAM, 73 estab-
lishedRAF, 22 establishedRAM, 13 NormalF, 14 NormalM.
(PDF)
S6 Fig. Neighbor joining tree based on the log fold-changes of significantly different genes
(significant in any comparison). Origin for the fold-changes is normal/healthy (normal/
healthy is the 0-vector). The x-axis is based on the Manhattan distance of significant fold-
changes. The distance might be meaningless as an absolute value, but informative as relative
distance.
(TIF)
S7 Fig. Neighbor joining tree based on the log fold-changes of significantly different
miRNA genes (significant in any comparison). Origin for the fold-changes is normal/healthy
(normal/healthy is the 0-vector). The x-axis is the distance. The distance might be meaningless
as an absolute value, but informative as relative distance.
(TIF)
S8 Fig. Hierarchical clustering based on the log fold-changes of significantly different
genes (significant in any comparison). Origin for the fold-changes is normal/healthy (nor-
mal/healthy is the 0-vector). The x-axis is the distance. The distance might be meaningless as
an absolute value, but informative as relative distance.
(TIF)
S9 Fig. Hierarchical clustering based on the log fold-changes of significantly different
miRNA genes (significant in any comparison). Origin for the fold-changes is normal/healthy
(normal/healthy is the 0-vector). The x-axis is the distance. The distance might be meaningless
as an absolute value, but informative as relative distance.
(TIF)
S10 Fig. Log2 fold-changes of gene expression between men and women in established/
long RA and normal condition. Only genes are shown which are significantly differentially
expressed in men and women. The size and shape shows the significance in differences of men
and women: the large circles are genes significantly differentially expressed between the sexes
in established/long RA and normal condition, these genes are also labelled. Small squares
mean a significant difference between men and woman only in established/long RA, small dia-
monds mean a significant difference only between healthy men and woman. The color repre-
sents the significance of the difference in expression between normal and established/long RA.
(TIF)
S11 Fig. Log2 fold-changes of gene expression between men and women in OA and normal
condition. Only genes are shown which are significantly differentially expressed in men and
women. The size and shape shows the significance in differences of men and women: the large
circles are genes significantly differentially expressed between the sexes in OA and normal
condition. Small squares mean a significant difference between men and woman only in OA,
small diamonds mean a significant difference only between healthy men and woman. The
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color represents the significance of the difference in expression between normal and OA.
(TIF)
S12 Fig. Gene clusters. Genes were clustered into modules of co-expression and their module
eigengenes (ME) normalized expressions are shown here for all conditions. In panel B the
patients are split in male/female and diagnosis, in panel A the average value of male and female
is shown. The color and the size of the dots depict the first principal component per module
using the scaled expression of the respective genes of a module over all conditions. Parts of
panel B should be seen with caution as some groups have a very small sample size (arthralgiaM
and UAM). Pairwise significant differences of conditions within modules are in S5 Table.
These are summarized in panel B as color-code: purple rows and columns are not significantly
different to any condition in any module, gray cells are not significantly different to any condi-
tion within the particular module. Number of samples: 8 arthralgiaF, 2 arthralgiaM, 13 nor-
malF, 14 normalM, 13 OAF, 9 OAM, 19 RAtripleDMARD, 5 UAF, 1 UAM, 33 earlyRAF, 24
earlyRAM, 73 establishedRAF and 22 establishedRAM.
(TIF)
S13 Fig. The amount and the overlaps of up- and down-regulated genes for different RA
conditions. The base condition is normal, so the label ‘earlyRA’ means normal compared with
early RA. Up-regulated fractions are shown in green, down-regulated fractions are shown in
red; gray are fractions of genes which are not significantly differentially expressed. The full set
is the union of significantly differentially expression genes in all comparisons. The colors of
the arc connections are dependent on what they are connecting. Number of samples: 57 ear-
lyRA, 95 establishedRA, 27 normal and 19 RAtripleDMARD.
(TIF)
S14 Fig. The amount and the overlaps of up- and down-regulated genes for early RA, OA,
arthralgia and undifferentiated arthritis. The base condition is normal, so the label ‘earlyRA’
means normal compared with early RA. Up-regulated fractions are shown in green, down-reg-
ulated fractions in red; in gray are fractions of genes which are not significantly differentially
expressed. The full set is the union of significantly differentially expression genes in all com-
parisons in this Fig. The colors of the arc connections are dependent on what they are connect-
ing. Number of samples: 10 arthralgia, 57 earlyRA, 27 normal, 22 OA and 6 UA.
(TIF)
S15 Fig. Comparison of significantly differentially expressed genes. The base state of genes
is the normal condition, except for ‘OA->RA’ where it is OA (base state is the first one in ‘con-
dition <one> compared to condition <two>‘). The origins of the different sources or sets
(the ’Set1’ to ’Set5’) are listed in Table B in S1 Text.
(TIF)
S1 Table. Accession identifiers (SRA database) and number of samples per diagnosis.
(XLS)
S2 Table. The average fold-changes and counts of genes in certain comparisons when
genes are grouped according to their biotype.
(XLS)
S3 Table. Performance of different ML-methods for the classification Normal vs. earlyRA;
weka is used.
(XLS)
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S4 Table. The importance of variables for the classifications Normal vs. earlyRA and ear-
lyRA vs. notRAarth; information gain and reliefF is used from weka.
(XLS)
S5 Table. Pairwise significant differences of conditions within modules of the Weighted
gene correlation network analysis (WGCNA). The differences were tested with a Wilcoxon
test comparing the eigengene values of the samples of two conditions. The ’significant?’ col-
umn is on the Bonferroni-corrected p-value. Each combination is twice in the table (e.g. Nor-
malF vs. earlyRAF and earlyRAF vs. NormalF are the same).
(XLS)
S1 Text. Relocated supporting text. Contains the sections ’Clustering of genes’, ’Overlaps in
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53. Parra-Torres NM, Cázares-Raga FE, Kouri JB. Proteomic analysis of rat cartilage: the identification of
differentially expressed proteins in the early stages of osteoarthritis. Proteome science. 2014; 12
(1):55. https://doi.org/10.1186/s12953-014-0055-0 PMID: 25435813
54. Jin M, Ishida M, Katoh-Fukui Y, Tsuchiya R, Higashinakagawa T, Ikegami S, et al. Reduced pain sen-
sitivity in mice lacking latexin, an inhibitor of metallocarboxypeptidases. Brain Res. 2006; 1075
(1):117–21. Epub 2006/02/14. https://doi.org/10.1016/j.brainres.2005.12.099 PMID: 16469302.
55. Galligan C, Baig E, Bykerk V, Keystone E, Fish E. Distinctive gene expression signatures in rheuma-
toid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes and immunity.
2007; 8(6):480. https://doi.org/10.1038/sj.gene.6364400 PMID: 17568789
56. Ashurst J, Chen C-K, Gilbert JG, Jekosch K, Keenan S, Meidl P, et al. The vertebrate genome annota-
tion (Vega) database. Nucleic acids research. 2005;33(suppl_1):D459-D65.
57. Batliwalla F, Baechler E, Xiao X, Li W, Balasubramanian S, Khalili H, et al. Peripheral blood gene
expression profiling in rheumatoid arthritis. Genes and immunity. 2005; 6(5):388. https://doi.org/10.
1038/sj.gene.6364209 PMID: 15973463
58. Niu X, Lu C, Xiao C, Zhang Z, Jiang M, He D, et al. The shared crosstalk of multiple pathways involved
in the inflammation between rheumatoid arthritis and coronary artery disease based on a digital gene
expression profile. PLoS One. 2014; 9(12):e113659. Epub 2014/12/17. https://doi.org/10.1371/
journal.pone.0113659 PMID: 25514790; PubMed Central PMCID: PMC4267808.
59. Teixeira VH, Olaso R, Martin-Magniette ML, Lasbleiz S, Jacq L, Oliveira CR, et al. Transcriptome anal-
ysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid
arthritis patients. PLoS One. 2009; 4(8):e6803. Epub 2009/08/28. https://doi.org/10.1371/journal.
pone.0006803 PMID: 19710928; PubMed Central PMCID: PMC2729373.
60. Yoshida S, Arakawa F, Higuchi F, Ishibashi Y, Goto M, Sugita Y, et al. Gene expression analysis of
rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection:
up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5. Scand J Rheu-
matol. 2012; 41(3):170–9. Epub 2012/03/10. https://doi.org/10.3109/03009742.2011.623137 PMID:
22401175; PubMed Central PMCID: PMC3400100.
61. D’hont A, Denoeud F, Aury J-M, Baurens F-C, Carreel F, Garsmeur O, et al. The banana (Musa acu-
minata) genome and the evolution of monocotyledonous plants. Nature. 2012; 488(7410):213. https://
doi.org/10.1038/nature11241 PMID: 22801500
62. Aidinis V, Carninci P, Armaka M, Witke W, Harokopos V, Pavelka N, et al. Cytoskeletal rearrange-
ments in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthri-
tis. PLoS genetics. 2005; 1(4):e48. https://doi.org/10.1371/journal.pgen.0010048 PMID: 16254600
63. Vasilopoulos Y, Gkretsi V, Armaka M, Aidinis V, Kollias G. Actin cytoskeleton dynamics linked to syno-
vial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis. Annals of the rheumatic
diseases. 2007; 66(suppl 3):iii23–iii8.
64. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nature
Reviews Immunology. 2008; 8(9):737. https://doi.org/10.1038/nri2394 PMID: 18728636
65. Furer V, Greenberg JD, Attur M, Abramson SB, Pillinger MH. The role of microRNA in rheumatoid
arthritis and other autoimmune diseases. Clin Immunol. 2010; 136(1):1–15. Epub 2010/03/13. https://
doi.org/10.1016/j.clim.2010.02.005 PMID: 20223711.
66. Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, et al. MicroRNA-124a is a
key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like syno-
viocytes from patients with rheumatoid arthritis. Arthritis Rheum. 2009; 60(5):1294–304. Epub 2009/
05/01. https://doi.org/10.1002/art.24475 PMID: 19404929.
Sex-bias, gene biotypes and co-expression patterns in rheumatoid arthritis and related conditions
PLOS ONE | https://doi.org/10.1371/journal.pone.0219698 July 25, 2019 20 / 23
67. Li G, Zhang Y, Qian Y, Zhang H, Guo S, Sunagawa M, et al. Interleukin-17A promotes rheumatoid
arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expres-
sion through NF-kappaB/HIF-1alpha pathway. Mol Immunol. 2013; 53(3):227–36. Epub 2012/09/11.
https://doi.org/10.1016/j.molimm.2012.08.018 PMID: 22960198.
68. Konisti S, Kiriakidis S, Paleolog EM. Hypoxia—a key regulator of angiogenesis and inflammation in
rheumatoid arthritis. Nat Rev Rheumatol. 2012; 8(3):153–62. Epub 2012/02/02. https://doi.org/10.
1038/nrrheum.2011.205 PMID: 22293762.
69. Pollard L, Choy E, Gonzalez J, Khoshaba B, Scott D. Fatigue in rheumatoid arthritis reflects pain, not
disease activity. Rheumatology. 2006; 45(7):885–9. https://doi.org/10.1093/rheumatology/kel021
PMID: 16449363
70. Nicklin J, Cramp F, Kirwan J, Greenwood R, Urban M, Hewlett S. Measuring fatigue in rheumatoid
arthritis: A cross-sectional study to evaluate the bristol rheumatoid arthritis fatigue multi-dimensional
questionnaire, visual analog scales, and numerical rating scales. Arthritis care & research. 2010; 62
(11):1559–68.
71. Leinonen R, Sugawara H, Shumway M, International Nucleotide Sequence Database C. The
sequence read archive. Nucleic Acids Res. 2011;39(Database issue):D19-21. Epub 2010/11/11.
https://doi.org/10.1093/nar/gkq1019 PubMed PMID: 21062823; PubMed Central PMCID:
PMC3013647.
72. Speir ML, Zweig AS, Rosenbloom KR, Raney BJ, Paten B, Nejad P, et al. The UCSC Genome
Browser database: 2016 update. Nucleic Acids Res. 2016; 44(D1):D717–25. Epub 2015/11/22.
https://doi.org/10.1093/nar/gkv1275 PMID: 26590259; PubMed Central PMCID: PMC4702902.
73. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformat-
ics. 2009; 25(9):1105–11. Epub 2009/03/18. https://doi.org/10.1093/bioinformatics/btp120 PMID:
19289445; PubMed Central PMCID: PMC2672628.
74. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9(4):357–
9. Epub 2012/03/06. https://doi.org/10.1038/nmeth.1923 PMID: 22388286; PubMed Central PMCID:
PMC3322381.
75. Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning
sequence reads to genomic features. Bioinformatics. 2014; 30(7):923–30. Epub 2013/11/15. https://
doi.org/10.1093/bioinformatics/btt656 PMID: 24227677.
76. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly
and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell dif-
ferentiation. Nat Biotechnol. 2010; 28(5):511–5. Epub 2010/05/04. https://doi.org/10.1038/nbt.1621
PMID: 20436464; PubMed Central PMCID: PMC3146043.
77. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression
analysis of digital gene expression data. Bioinformatics. 2010; 26(1):139–40. Epub 2009/11/17.
https://doi.org/10.1093/bioinformatics/btp616 PMID: 19910308; PubMed Central PMCID:
PMC2796818.
78. Yang J, Huang T, Petralia F, Long Q, Zhang B, Argmann C, et al. Synchronized age-related gene
expression changes across multiple tissues in human and the link to complex diseases. Sci Rep.
2015; 5:15145. Epub 2015/10/20. https://doi.org/10.1038/srep15145 PMID: 26477495; PubMed Cen-
tral PMCID: PMC4609956.
79. Radstake TR, van der Voort R, ten Brummelhuis M, de Waal Malefijt M, Looman M, Figdor CG, et al.
Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid
arthritis, and regulation by Fc gamma receptors. Ann Rheum Dis. 2005; 64(3):359–67. Epub 2004/08/
28. https://doi.org/10.1136/ard.2003.017566 PMID: 15331393; PubMed Central PMCID:
PMC1755402.
80. Flytlie HA, Hvid M, Lindgreen E, Kofod-Olsen E, Petersen EL, Jorgensen A, et al. Expression of MDC/
CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Cytokine.
2010; 49(1):24–9. Epub 2009/11/28. https://doi.org/10.1016/j.cyto.2009.10.005 PMID: 19942450.
81. Lee AY, Korner H. CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis.
Immunol Cell Biol. 2014; 92(4):354–8. Epub 2014/01/08. https://doi.org/10.1038/icb.2013.97 PMID:
24394994.
82. Rodriguez PC, Torres-Moya R, Reyes G, Molinero C, Prada D, Lopez AM, et al. A clinical exploratory
study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis. Results
Immunol. 2012; 2:204–11. Epub 2012/01/01. https://doi.org/10.1016/j.rinim.2012.11.001 PMID:
24371585; PubMed Central PMCID: PMC3862386.
83. Valencia X, Higgins JM, Kiener HP, Lee DM, Podrebarac TA, Dascher CC, et al. Cadherin-11 provides
specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med. 2004; 200(12):1673–9.
Sex-bias, gene biotypes and co-expression patterns in rheumatoid arthritis and related conditions
PLOS ONE | https://doi.org/10.1371/journal.pone.0219698 July 25, 2019 21 / 23
Epub 2004/12/22. https://doi.org/10.1084/jem.20041545 PMID: 15611293; PubMed Central PMCID:
PMC2211995.
84. Castaneda-Delgado JE, Bastian-Hernandez Y, Macias-Segura N, Santiago-Algarra D, Castillo-Ortiz
JD, Aleman-Navarro AL, et al. Type I Interferon Gene Response Is Increased in Early and Established
Rheumatoid Arthritis and Correlates with Autoantibody Production. Front Immunol. 2017; 8:285. Epub
2017/04/05. https://doi.org/10.3389/fimmu.2017.00285 PMID: 28373872; PubMed Central PMCID:
PMC5357778.
85. Corvaisier M, Delneste Y, Jeanvoine H, Preisser L, Blanchard S, Garo E, et al. IL-26 is overexpressed
in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation.
PLoS Biol. 2012; 10(9):e1001395. Epub 2012/10/12. https://doi.org/10.1371/journal.pbio.1001395
PMID: 23055831; PubMed Central PMCID: PMC3463509.
86. Ruyssen-Witrand A, Lukas C, Nigon D, Dawidowicz K, Morel J, Sibilia J, et al. Association of IL-2RA
and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP
cohorts). Joint Bone Spine. 2014; 81(3):228–34. Epub 2013/11/10. https://doi.org/10.1016/j.jbspin.
2013.10.002 PMID: 24200909.
87. Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, et al. Invasive
properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of
MMP-1, MMP-3, and MMP-10. Ann Rheum Dis. 2002; 61(11):975–80. Epub 2002/10/16. https://doi.
org/10.1136/ard.61.11.975 PMID: 12379519; PubMed Central PMCID: PMC1753950.
88. Liu M, Sun H, Wang X, Koike T, Mishima H, Ikeda K, et al. Association of increased expression of mac-
rophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. Arthritis Rheum. 2004; 50
(10):3112–7. Epub 2004/10/12. https://doi.org/10.1002/art.20567 PMID: 15476203.
89. Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in
arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription
factors. Arthritis Res. 2002; 4(3):157–64. Epub 2002/05/16. https://doi.org/10.1186/ar401 PMID:
12010565; PubMed Central PMCID: PMC128926.
90. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;
11(1):529–43.
91. Team RC. R: A language and environment for statistical computing. 2015.
92. Van Der Maaten L, Postma E, Van den Herik J. Dimensionality reduction: a comparative. J Mach
Learn Res. 2009; 10:66–71.
93. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bio-
informatics. 2008; 9:559. Epub 2008/12/31. https://doi.org/10.1186/1471-2105-9-559 PMID:
19114008; PubMed Central PMCID: PMC2631488.
94. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics.
2007; 23(2):257–8. Epub 2006/11/14. https://doi.org/10.1093/bioinformatics/btl567 PMID: 17098774.
95. Subhash S, Kanduri C. GeneSCF: a real-time based functional enrichment tool with support for multi-
ple organisms. BMC Bioinformatics. 2016; 17(1):365. Epub 2016/09/14. https://doi.org/10.1186/
s12859-016-1250-z PMID: 27618934; PubMed Central PMCID: PMC5020511.
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